Gene Editing is the ability to make highly specific changes in the DNA sequence of a living organism, essentially customizing its genetic makeup. It demonstrates great potential in gene research, gene therapy and genetic improvement. The Gene Editing concept includes major US-listed companies whose businesses are involved in gene editing.
Sangamo Stock Climbs 12% Post-market on FDA Update for ST-503
Bitcoin Climbs to Fresh High, Market Shifts into Climb | Wall Street Today
Sangamo Therapeutics Gets FDA Clearance Of IND Application For ST-503 For Treatment Of Idiopathic Small Fiber Neuropathy
Tuesday Market Falls, SMCI Flies, Big Box Retail Reports Mixed | Live Stock
Astellas Receives Complete Response Letter From FDA for Izervay SNDA
Lilly Heart Drug Muvalaplin Significantly Reduces Lipoprotein(a) Levels